Eileen M. O'Reilly, MD

David M. Rubenstein Center for Pancreatic Cancer Research, Memorial Sloan Kettering Cancer Center, Weil Cornell Medical College, New York, New York, USA

Dr. Eileen M. O’Reilly serves as the Section Head for Hepatopancreaticobiliary and Neuroendocrine Cancers, Gastrointestinal Oncology Service, Associate Director for the David M. Rubenstein Center for Pancreatic Cancer at Memorial Sloan Kettering (MSK) in New York and Attending Physician and Member at MSK and Professor of Medicine at Weill Cornell Medical College. Dr. O’Reilly received her medical degree at Trinity College (Dublin University) in Ireland, where she was born. She completed her residency training in Ireland and Fellowship training at MSKCC. Dr. O’Reilly has pancreatic and hepatobiliary malignancies as the major focus of her research and clinical activities. Research initiatives include integration of molecular and genetic-based therapies for the treatment of pancreas cancer along with development of adjuvant and neoadjuvant therapies and identification of biomarkers that maybe used to select therapy. Dr. O’Reilly teaches and mentors oncology fellows, junior faculty, residents and house-staff and has numerous teaching and other awards. Dr. O’Reilly is the Principal Investigator of multiple phase I, II and III trials in pancreas cancer and has authored/co-authored multiple articles, editorials and book chapters. Dr. O’Reilly’s institutional responsibilities include Associate Chairpersonship of MSK’s Institutional Review & Privacy Board (IRB), Chair of the Data and Safety Monitoring Committee (DSMC) and Chair of the Continuing Medical Education (CME) committee. Nationally Dr. O’Reilly is the Co-Chair of the Alliance Co-Operative Group Gastrointestinal Cancers Committee, and serves on the Medical and Scientific Advisory Board of the Pancreatic Cancer Action Network, NCCN Pancreas panel, ASCO Guidelines Committee and the Board of the National Pancreas Foundation.